Ursolic acid inhibits T-cell activation through modulating nuclear factor-κ B signaling

Chinese Journal of Integrative Medicine

Volumn 18, Issue 1, 2012, Pages 34-39

  Zeng, Guang ^a   Chen, Jiang ^a   Liang, Qing Hua ^a   You, Wan Hui ^a   Wu, Han Jun ^a   Xiong, Xin Gui ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

CD25; CD69; CD71; nuclear factor B; T cell activation; ursolic acid

Indexed keywords

CD69 ANTIGEN; CD71 ANTIGEN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR RELA; URSOLIC ACID;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; CELL NUCLEUS; CELL PROLIFERATION; I-KAPPA B PROTEINS; INTERLEUKIN-2; IONOMYCIN; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; NF-KAPPA B; PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE; TRITERPENES;

EID: 84856282738     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-011-0858-0     Document Type: Article

References (30)

1. H. Nishino A. Nishino J. Takayasu T. Hasegawa A. Iwashima K. Hirabayashi, et al. 1988 Inhibition of the tumor-promoting action of 12-O- tetradecanoylphorbol-13-acetate by some oleanane-type triterpenoid compounds Cancer Res 48 5210 5215 3409245 1:CAS:528:DyaL1MXhvVWktA%3D%3D
2. S.F. Ahmad B. Khan S. Bani K.A. Suri N.K. Satti G.N. Qazi 2006 Amelioration of adjuvant-induced arthritis by ursolic acid through altered Th1/Th2 cytokine production Pharmacol Res 53 233 240 16406805 10.1016/j.phrs.2005.11.005 1:CAS:528:DC%2BD28XhsFylsrw%3D (Pubitemid 43247535)
3. T. Tsuruga Y.T. Chun Y. Ebizuka U. Sankawa 1991 Biologically active constituents of Melaleuca leucadendron: inhibitors of induced histamine release from rat mast cells Chem Pharm Bull (Tokyo) 39 3276 3278 10.1248/cpb.39.3276 1:CAS:528:DyaK38Xhs1Gktbk%3D
4. N. Suh T. Honda H.J. Finlay A. Barchowsky C. Williams N.E. Benoit, et al. 1998 Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages Cancer Res 58 717 723 9485026 1:CAS:528:DyaK1cXht1anuro%3D (Pubitemid 28099483)
5. Q.L. Ying A.R. Rinehart S.R. Simon J.C. Cheronis 1991 Inhibition of human leucocyte elastase by ursolic acid. Evidence for a binding site for pentacyclic triterpenes Biochem J 277 521 526 1859379 1:CAS:528:DyaK3MXlsFeksr4%3D
6. D.A. Fox 1997 The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives Arthritis Rheum 40 598 609 9125240 10.1002/art.1780400403 1:STN:280:DyaK2s3ksVaqsA%3D%3D (Pubitemid 27157563)
7. G.S. Panayi V.M. Corrigall C. Pitzalis 2001 Pathogenesis of rheumatoid arthritis. The role of T cells and other beasts Rheum Dis Clin North Am 27 317 334 11396095 10.1016/S0889-857X(05)70204-0 1:STN:280:DC%2BD3MzivVKnsA%3D%3D (Pubitemid 32488708)
8. J.Z. Shan Y.Y. Xuan S. Zheng Q. Dong S.Z. Zhang 2009 Ursolic acid inhibits proliferation and induces apoptosis of HT-29 colon cancer cells by inhibiting the EGFR/MAPK pathway J Zhejiang Univ Sci 10B 668 674
9. C.Y. Leung L. Liu R.N. Wong Y.Y. Zeng M. Li H. Zhou 2005 Saikosaponin-d inhibits T cell activation through the modulation of PKCtheta, JNK, and NF-kappaB transcription factor Biochem Biophys Res Commun 338 920 927 10.1016/j.bbrc.2005.10.175 (Pubitemid 41643109)
10. J. Liu 2005 Oleanolic acid and ursolic acid: research perspectives J Ethnopharmacol 100 92 94 15994040 10.1016/j.jep.2005.05.024 1:CAS:528: DC%2BD2MXmvVKnsbw%3D (Pubitemid 41073528)
11. S. Valitutti M. Dessing K. Aktories H. Gallati A. Lanzavecchia 1995 Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton J Exp Med 181 577 584 7836913 10.1084/jem.181.2.577 1:CAS:528:DyaK2MXjtFyhu7Y%3D
12. M.A. Goldsmith A. Weiss 1988 Early signal transduction by the antigen receptor without commitment to T cell activation Science 240 1029 1031 3259335 10.1126/science.3259335 1:CAS:528:DyaL1cXktlKntro%3D
13. R. Marzio J. Mauel S. Betz-Corradin 1999 CD69 and regulation of the immune function Immunopharmacol Immunotoxicol 21 565 582 10466080 10.3109/08923979909007126 1:CAS:528:DyaK1MXmtV2kt7Y%3D (Pubitemid 29409367)
14. K.O. Schowengerdt F.J. Fricker K.S. Bahjat S.T. Kuntz 2000 Increased expression of the lymphocyte early activation marker CD69 in peripheral blood correlates with histologic evidence of cardiac allograft rejection Transplantation 69 2102 2107 10852605 10.1097/00007890-200005270-00023 1:CAS:528:DC%2BD3cXksF2rtLs%3D (Pubitemid 30395042)
15. A.M. Posselt F. Vincenti M. Bedolli M. Lantz J.P. Roberts R. Hirose 2003 CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients Transplantation 76 190 195 12865808 10.1097/01.TP.0000073614.29680.A8 1:CAS:528:DC%2BD3sXlsVymsL0%3D (Pubitemid 36877135)
16. K.S. Ullman J.P. Northrop C.L. Verweij G.R. Crabtree 1990 Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link Annu Rev Immunol 8 421 452 2188669 10.1146/annurev.iy.08.040190.002225 1:CAS:528:DyaK3cXkslGqsLg%3D (Pubitemid 20135634)
17. J.A. Symons N.C. Wood G.F.S. Di G.W. Duff 1988 Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition J Immunol 141 2612 2618 3262665 1:CAS:528:DyaL1cXmtV2ms70%3D (Pubitemid 18263042)
18. S.L. Gaffen S. Wang M.E. Koshland 1996 Expression of the immunoglobulin J chain in a murine B lymphoma is driven by autocrine production of interleukin 2 Cytokine 8 513 524 8891432 10.1006/cyto.1996.0070 1:CAS:528:DyaK28XmtFejtr8%3D (Pubitemid 26294541)
19. C.G. McFarlane M.C. Meikle 1991 Interleukin-2, interleukin-2 receptor and interleukin-4 levels are elevated in the sera of patients with periodontal disease J Periodontal Res 26 402 408 1832452 10.1111/j.1600-0765.1991.tb01729.x 1:STN:280:DyaK3Mzms1Gnsw%3D%3D
20. J.G. Tebib H. Boughaba M.C. Letroublon J. Bienvenu E. Noel P. Armanet, et al. 1991 Serum IL-2 level in rheumatoid arthritis: correlation with joint destruction and disease progression Eur Cytokine Netw 2 239 243 1756229 1:STN:280:DyaK38%2Fps1Gmtw%3D%3D
21. P.P. Tak G.S. Firestein 2001 NF-kappaB: a key role in inflammatory diseases J Clin Invest 107 7 11 11134171 10.1172/JCI11830 1:CAS:528: DC%2BD3MXitVOhtg%3D%3D (Pubitemid 32047405)
22. P.A. Baeuerle D. Baltimore 1988 Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NFkappa B transcription factor Cell 53 211 217 3129195 10.1016/0092-8674(88)90382-0 1:CAS:528:DyaL1cXktlaqu7s%3D
23. P.A. Baeuerle D. Baltimore 1988 I kappa B: a specific inhibitor of the NF-kappa B transcription factor Science 242 540 546 3140380 10.1126/science. 3140380 1:CAS:528:DyaL1cXmt1yiuro%3D (Pubitemid 18263193)
24. A.A. Beg S.M. Ruben R.I. Scheinman S. Haskill C.A. Rosen A.S. Baldwin Jr. 1992 I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention Genes Dev 6 1899 1913 1340770 10.1101/gad.6.10.1899 1:CAS:528:DyaK38Xmt1ymtbk%3D
25. A.A. Beg A.S. Baldwin Jr 1993 The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors Genes Dev 7 2064 2070 8224838 10.1101/gad.7.11.2064 1:CAS:528:DyaK2cXisFKktw%3D%3D
26. K. Brown S. Park T. Kanno G. Franzoso U. Siebenlist 1993 Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha Proc Natl Acad Sci USA 90 2532 2536 8460169 10.1073/pnas.90.6.2532 1:CAS:528:DyaK3sXktVagtbo%3D (Pubitemid 23078662)
27. T. Henkel T. Machleidt I. Alkalay M. Kronke Y. Ben-Neriah P.A. Baeuerle 1993 Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B Nature 365 182 185 8371761 10.1038/365182a0 1:CAS:528:DyaK3sXms1equ74%3D (Pubitemid 23282067)
28. M.J. Lenardo D. Baltimore 1989 NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control Cell 58 227 229 2665943 10.1016/0092-8674(89)90833-7 1:CAS:528:DyaL1MXltFehtLw%3D (Pubitemid 19191405)
29. H.J. You C.Y. Choi J.Y. Kim S.J. Park K.S. Hahm H.G. Jeong 2001 Ursolic acid enhances nitric oxide and tumor necrosis factor-alpha production via nuclear factor-kappaB activation in the resting macrophages FEBS Lett 509 156 160 11741581 10.1016/S0014-5793(01)03161-1 1:CAS:528:DC%2BD3MXovF2iuro%3D (Pubitemid 34015934)
30. S. Shishodia S. Majumdar S. Banerjee B.B. Aggarwal 2003 Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of I kappaBalpha kinase and p65 phosphorylation: correlation with downregulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1 Cancer Res 63 4375 4383 12907607 1:CAS:528:DC%2BD3sXmtFeku70%3D (Pubitemid 36951006)